AU Patent

AU2016208310B2 — Androgen receptor modulators and uses thereof

Assigned to Aragon Pharmaceuticals Inc · Expires 2017-10-05 · 9y expired

What this patent protects

Androgen Receptor Modudators and Uses Thereof Abstract Described herein are compounds that axe androgen receptfor modulators. Also described are pham-aceutical compositions and medicaments that inchide the compounds described herein. as well as methods of using such andogen recep…

USPTO Abstract

Androgen Receptor Modudators and Uses Thereof Abstract Described herein are compounds that axe androgen receptfor modulators. Also described are pham-aceutical compositions and medicaments that inchide the compounds described herein. as well as methods of using such andogen receptor modulators, alone and in combination with other compounds, for treating diseases ofr condnions that are mdiated or dependent upon androgen receptors.

Drugs covered by this patent

Patent Metadata

Patent number
AU2016208310B2
Jurisdiction
AU
Classification
—
Expires
2017-10-05
Drug substance claim
No
Drug product claim
No
Assignee
Aragon Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.